143 results on '"Csóka, Monika"'
Search Results
2. Digital PCR-based quantification of miR-181a in the cerebrospinal fluid aids patient stratification in pediatric acute lymphoblastic leukemia
3. Cost-effectiveness analysis alongside the inter-B-NHL ritux 2010 trial: rituximab in children and adolescents with B cell non-Hodgkin’s lymphoma
4. Novel actionable ROS1::GIT2 fusion in non-Langerhans cell histiocytosis with central nervous system involvement
5. Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trial
6. Osteosarcoma and causes of death: A report of 1520 deceased patients from the Cooperative Osteosarcoma Study Group (COSS)
7. The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries
8. Distance measurement for pulse wave velocity estimation in pediatric age: Comparison with intra-arterial path length
9. The Impact of Qualification and Hospice Education on Staff Attitudes during Palliative Care in Pediatric Oncology Wards—A National Survey
10. Quantitative RT-PCR-based miRNA profiling of blastemal Wilms’ tumors from formalin-fixed paraffin-embedded samples
11. The Presence of ALK Alterations and Clinical Relevance of Crizotinib Treatment in Pediatric Solid Tumors
12. Large B-cell lymphoma-IRF4+ in children and young people: time to reduce chemotherapy in a rare malignant mature B-cell neoplasm?
13. Alterations of miRNA Expression in Diffuse Hyperplastic Perilobar Nephroblastomatosis: Mapping the Way to Understanding Wilms’ Tumor Development and Differential Diagnosis
14. Cost-effectiveness analysis alongside the inter-B-NHL ritux 2010 trial: rituximab in children and adolescents with B cell non-Hodgkin’s lymphoma
15. Case report: Complete and durable response to larotrectinib (TRK inhibitor) in an infant diagnosed with angiosarcoma harbouring a KHDRBS1-NTRK3 fusion gene
16. Novel actionable ROS1::GIT2 fusion in non-Langerhans cell histiocytosis with central nervous system involvement
17. Expression of Certain Leukemia/Lymphoma Related microRNAs and its Correlation with Prognosis in Childhood Acute Lymphoblastic Leukemia
18. Clinical Course of COVID-19 Disease in Children Treated With Neoplastic Diseases in Hungary
19. In Situ Analysis of mTORC1/C2 and Metabolism-Related Proteins in Pediatric Osteosarcoma
20. Osteosarcoma and Causes of Death. A Report of 1.520 Deceased Patients from the Cooperative Osteosarcoma Study Group (COSS)
21. Incidence of Retinoblastoma Has Increased: Results from 40 European Countries
22. Six Cases of Rare Gene Amplifications and Multiple Copy of Fusion Gene in Childhood Acute Lymphoblastic Leukemia
23. miRNA Profiling of Hungarian Regressive Wilms’ Tumor Formalin-Fixed Paraffin-Embedded (FFPE) Samples by Quantitative Real-Time Polymerase Chain Reaction (RT-PCR)
24. A gyermekkori koronavírus-fertőzést követő sokszervi gyulladás diagnosztikája és kezelése
25. Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries
26. Characterization of mTOR Activity and Metabolic Profile in Pediatric Rhabdomyosarcoma
27. Juvenile myelomonocytic leukaemia presentation after preceding juvenile xanthogranuloma harbouring an identical somatic PTPN11 mutation
28. Treatment of Pediatric Non-Hodgkin Lymphoma in Hungary: 15 Years Experience With NHL-BFM 90 and 95 Protocols
29. PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA IN HUNGARY: P.D.096
30. Subacute cardiotoxicity caused by anthracycline therapy in children: can dexrazoxane prevent this effect?
31. High-Grade Osteosarcoma of the Foot: Presentation, Treatment, Prognostic Factors, and Outcome of 23 Cooperative Osteosarcoma Study Group COSS Patients
32. Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries
33. The Presence of ALK Alterations and Clinical Relevance of Crizotinib Treatment in Pediatric Solid Tumors
34. Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim–Chester disease
35. Global Retinoblastoma Presentation and Analysis by National Income Level
36. Primary alveolar rhabdomyosarcoma of the bone: two cases and review of the literature
37. Some GCR Polymorphisms (N363S, ER22/23EK, and Bcl-1) May Influence Steroid-induced Toxicities and Survival Rates in Children With ALL
38. CD8+/FOXP3+-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study
39. Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim-Chester disease.
40. Expression of Certain Leukemia/Lymphoma Related microRNAs and its Correlation with Prognosis in Childhood Acute Lymphoblastic Leukemia
41. Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease – a combined tissue microarray, in vitro and in vivo study
42. Mammalian Target of Rapamycin (mTOR) Activity Dependent Phospho-Protein Expression in Childhood Acute Lymphoblastic Leukemia (ALL)
43. Six Cases of Rare Gene Amplifications and Multiple Copy of Fusion Gene in Childhood Acute Lymphoblastic Leukemia
44. Pharmacokinetic analysis of high-dose methotrexate treatments in children with hematologic malignancies
45. Lymphomák adoleszcens korban: Érdemes-e gyermek-protokollal kezelni ezt a betegcsoportot?
46. Hodgkin’s lymphoma in adolescents
47. A hagyományos citogenetika és a FISH egymást jól kiegészítő vizsgálatok gyermekkori akut limfoid leukémiában
48. Intrachromosomal amplification of AML1 gene in childhood acute lymphoblastic leukemia
49. Subacute cardiotoxicity caused by anthracycline therapy in children: can dexrazoxane prevent this effect?
50. HUNGARIAN EXPERIENCE WITH LANGERHANS CELL HISTIOCYTOSIS IN CHILDHOOD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.